Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

Related Articles
Single-Lead ECG Tracings from an Apple Watch Effectively Identifies Patients with a Weak Heart Pump
AZO Robotics: Patients with a weak heart pump were identified using single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic. Researchers…May 01, 2022
Trial demonstrates early AI-guided detection of heart disease in routine practice
Medical Xpress: Heart disease can take a number of forms, but some types of heart disease, such as asymptomatic low ejection fraction, can be hard to recognize, especially in the…May 15, 2021
Anumana Joins Accelerating Medicines Partnership Heart Failure Program to Advance ECG-AI® Research
Program provides access to real-world data to refine AI algorithms for earlier detection of complex heart conditionsOctober 24, 2024
Anumana Appoints Maulik Nanavaty as CEO
Anumana Appoints Maulik Nanavaty as CEOCAMBRIDGE, Mass. – October 19, 2023 – Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, today announced that Maulik Nanavaty…October 19, 2023


